Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Source: SeekingAlpha
2026-03-06 08:28:08 ET
More on Thermo Fisher Scientific, Arcutis Biotherapeutics, etc.
- Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
- Elanco Animal Health Incorporated (ELAN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Thermo Fisher Scientific: Recovery In Life Sciences Solutions
- Masimo Q4 2025 Earnings Preview
- Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum
Read the full article on Seeking Alpha
For further details see:
Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Thermo Fisher Scientific Inc
NASDAQ: TMO
TMO Trading
-1.67% G/L:
$469.88 Last:
854,238 Volume:
$478.93 Open:
TMO Latest News
February 24, 2026 08:00:00 am
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference
February 04, 2026 11:18:37 am
C WorldWide Group Loads Up 45,000 MercadoLibre Shares Worth $94 Million
TMO Stock Data
$204,210,479,849
375,369,922
0.04%
1541
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
